Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in rats.
Li T, Shen Y, Lin F, Fu W, Liu S, Wang C, Liang J, Fan X, Ye X, Tang Y, Ding M, Yang Y, Lei C, Hu S.
Li T, et al. Among authors: ding m.
FASEB J. 2019 Jun;33(6):7467-7478. doi: 10.1096/fj.201802354R. Epub 2019 Mar 18.
FASEB J. 2019.
PMID: 30885011
., Fu, W., Liu, S., Wang, C., Liang, J., Fan, X., Ye, X., Tang, Y., Ding, M., Yang, Y., Lei, C., Hu, S. Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in rats....
., Fu, W., Liu, S., Wang, C., Liang, J., Fan, X., Ye, X., Tang, Y., Ding, M., Yang, Y., Lei, C., Hu, S. Targeting RyR2 with a …